Corrigendum to "Exogenous recombinant N-acetylgalactosamine-4-sulfatase (Arylsulfatase B; ARSB) inhibits progression of B16F10 cutaneous melanomas and modulates cell signaling" [Biochim. Biophys. Acta Mol. Basis Dis. 1870(1) (2024)166913-25, PMID: 37813168]

Affiliations

• ¹ Jesse Brown VA Medical Center, Chicago, IL 60612, USA; Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
• ² Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL 60612, USA.
• ³ Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL 60612, USA; Biostatistics Shared Resource, University of Illinois Cancer Center, Chicago, IL 60612, USA.
• ⁴ Jesse Brown VA Medical Center, Chicago, IL 60612, USA; Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA. Electronic address: jkt@uic.edu.